DOCGO INC (DCGO)
US2560861096 - Common Stock
We assign a fundamental rating of 5 out of 10 to DCGO. DCGO was compared to 115 industry peers in the Health Care Providers & Services industry. DCGO has an average financial health and profitability rating. DCGO is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
DCGO had positive earnings in the past year.
In the past year DCGO has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: DCGO reported negative net income in multiple years.
In the past 5 years DCGO reported 4 times negative operating cash flow.
1.2 Ratios
DCGO's Return On Assets of 6.17% is amongst the best of the industry. DCGO outperforms 88.60% of its industry peers.
DCGO's Return On Equity of 9.56% is fine compared to the rest of the industry. DCGO outperforms 75.44% of its industry peers.
DCGO's Return On Invested Capital of 9.18% is amongst the best of the industry. DCGO outperforms 86.84% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for DCGO is below the industry average of 7.72%.
The last Return On Invested Capital (9.18%) for DCGO is above the 3 year average (4.74%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.17% | ||
| ROE | 9.56% | ||
| ROIC | 9.18% |
ROA(3y)5.95%
ROA(5y)N/A
ROE(3y)8.58%
ROE(5y)N/A
ROIC(3y)4.74%
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 4.06%, DCGO belongs to the best of the industry, outperforming 82.46% of the companies in the same industry.
DCGO has a better Operating Margin (7.30%) than 76.32% of its industry peers.
With a decent Gross Margin value of 32.97%, DCGO is doing good in the industry, outperforming 62.28% of the companies in the same industry.
In the last couple of years the Gross Margin of DCGO has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.3% | ||
| PM (TTM) | 4.06% | ||
| GM | 32.97% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.01%
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DCGO is creating some value.
DCGO has more shares outstanding than it did 1 year ago.
The debt/assets ratio for DCGO is higher compared to a year ago.
2.2 Solvency
DCGO has an Altman-Z score of 3.52. This indicates that DCGO is financially healthy and has little risk of bankruptcy at the moment.
DCGO has a better Altman-Z score (3.52) than 78.07% of its industry peers.
A Debt/Equity ratio of 0.12 indicates that DCGO is not too dependend on debt financing.
DCGO's Debt to Equity ratio of 0.12 is fine compared to the rest of the industry. DCGO outperforms 73.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.52 |
ROIC/WACC1.12
WACC8.21%
2.3 Liquidity
DCGO has a Current Ratio of 2.13. This indicates that DCGO is financially healthy and has no problem in meeting its short term obligations.
DCGO's Current ratio of 2.13 is fine compared to the rest of the industry. DCGO outperforms 78.07% of its industry peers.
DCGO has a Quick Ratio of 2.13. This indicates that DCGO is financially healthy and has no problem in meeting its short term obligations.
DCGO's Quick ratio of 2.13 is amongst the best of the industry. DCGO outperforms 80.70% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.13 | ||
| Quick Ratio | 2.13 |
3. Growth
3.1 Past
DCGO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 383.33%, which is quite impressive.
Looking at the last year, DCGO shows a very strong growth in Revenue. The Revenue has grown by 64.50%.
Measured over the past years, DCGO shows a very strong growth in Revenue. The Revenue has been growing by 87.90% on average per year.
EPS 1Y (TTM)383.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%450%
Revenue 1Y (TTM)64.5%
Revenue growth 3Y87.9%
Revenue growth 5YN/A
Sales Q2Q%31.45%
3.2 Future
The Earnings Per Share is expected to grow by 37.27% on average over the next years. This is a very strong growth
DCGO is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -9.16% yearly.
EPS Next Y280.94%
EPS Next 2Y33.49%
EPS Next 3Y37.27%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y-18.18%
Revenue Next 3Y-9.16%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 11.69 indicates a reasonable valuation of DCGO.
DCGO's Price/Earnings ratio is rather cheap when compared to the industry. DCGO is cheaper than 92.11% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 31.46. DCGO is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 27.18, which means the current valuation is very expensive for DCGO.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DCGO is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 22.63. DCGO is valued slightly more expensive when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.69 | ||
| Fwd PE | 27.18 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DCGO indicates a rather cheap valuation: DCGO is cheaper than 97.37% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 4.16 |
4.3 Compensation for Growth
DCGO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as DCGO's earnings are expected to grow with 37.27% in the coming years.
PEG (NY)0.04
PEG (5Y)N/A
EPS Next 2Y33.49%
EPS Next 3Y37.27%
5. Dividend
5.1 Amount
No dividends for DCGO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
DOCGO INC
NASDAQ:DCGO (10/22/2024, 3:11:55 PM)
3.39
-0.03 (-0.88%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap346.86M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.69 | ||
| Fwd PE | 27.18 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.04
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.17% | ||
| ROE | 9.56% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 7.3% | ||
| PM (TTM) | 4.06% | ||
| GM | 32.97% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.13 | ||
| Quick Ratio | 2.13 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)383.33%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y280.94%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)64.5%
Revenue growth 3Y87.9%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y